You are here
Radius Health Strengthens Senior Management Team with Appointment of Chhaya Shah as Senior Vice President of Technical Operations
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq:RDUS) today announced the appointment of Chhaya Shah as Senior Vice President of Technical Operations.
"Ms. Shah will help strengthen and expand our technical operations infrastructure, optimize our supply chain and ramp-up our manufacturing capabilities, supporting the development of our late-stage clinical pipeline to commercial readiness. Chhaya's more than 25 years of industry experience in supply chain, quality assurance, and manufacturing will be critical in guiding Radius through our operational and commercial transformation as we make significant progress with our two lead clinical assets, abaloparatide-patch and elacestrant,” said Jesper Høiland, President and Chief Executive Officer of Radius.
Ms. Shah joins Radius from Synergy Pharmaceuticals where she was the Senior Vice President of Manufacturing and Technical Operations and helped successfully launch their first commercial product. Prior to Synergy, Chhaya served various functions at Shire Pharmaceuticals, in which she was responsible for end-to-end supply chain for over 20 products, developed quality systems and supported global approval of multiple products, including pre-approval regulatory inspections. Before joining Shire, Chhaya held various compliance, quality assurance and manufacturing leadership roles at Wyeth Pharmaceuticals, Vaccine Division and Abbott Laboratories.
Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology. For more information, please visit www.radiuspharm.com.
Investor Relations Contact:
Elhan Webb, CFA